We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TDAY:NYSEUSA TODAY Co., Inc. Analysis

Data as of 2026-07-22 - not real-time

$8.57

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

USA TODAY Co., Inc. (TDAY) is trading at $8.57, comfortably above its 20‑day SMA of $8.48 and the 50‑day SMA of $8.02, indicating a short‑term bullish bias, but the MACD histogram has turned negative and the signal line is bearish, suggesting momentum may be waning. RSI sits at 56.7, well within the neutral zone, so there is no clear overbought signal, while the 30‑day volatility of 33% points to sizable price swings. Beta is low at 0.38, implying limited market‑wide risk, yet the decreasing volume trend raises concerns about liquidity support for the rally. The stock’s trailing PE of 47.6 dwarfs the industry average of 16, and a DCF fair‑value estimate of $1.93 implies the market is pricing in expectations far beyond current fundamentals, leaving only a modest 3% upside per the upside/downside metric. Debt is a major red flag, with a debt‑to‑equity ratio over 800 and total debt exceeding $1.1 bn, while cash balances are modest at $85 m, creating a strained balance sheet. Revenue is contracting (-4%) and profit margins are thin (1.3% net), limiting organic growth prospects. The “Extreme Greed” sentiment on the Fear & Greed Index reflects market optimism that may be disconnected from the company’s cash‑flow reality. Overall, the technical setup shows a bullish trend but weakening momentum, and the valuation metrics flag significant overvaluation relative to fundamentals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above 20‑day SMA but MACD turning bearish
  • Neutral RSI and high short‑term volatility
  • Decreasing volume indicating weakening buying pressure

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Limited upside (~3%) versus current price
  • Heavy debt load and negative revenue growth
  • Valuation disparity (PE ~3× industry, DCF far below market)

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Sustained overvaluation and weak fundamentals
  • High leverage with minimal cash cushion
  • Potential for earnings compression if market sentiment shifts

Key Metrics & Analysis

Financial Health

Revenue Growth-4.00%
Profit Margin1.27%
P/E Ratio47.6
ROE19.91%
ROA4.69%
Debt/Equity800.37
P/B Ratio8.8
Op. Cash Flow$110.4M
Free Cash Flow$102.7M
Industry P/E16.0

Technical Analysis

TrendBullish
RSI56.7
Support$7.76
Resistance$8.90
MA 20$8.48
MA 50$8.02
MA 200$6.29
MACDBearish
VolumeDecreasing
Fear & Greed Index90.41

Valuation

Fair Value$1.93
Target Price$8.84
Upside/Downside3.17%
GradeOvervalued
TypeValue

Risk Assessment

Beta0.38
Volatility33.34%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.